Demethylation
Showing 1 - 25 of 101
MDS Trial (Yisui granule, Placebo)
Not yet recruiting
- MDS
- Yisui granule
- Placebo
- (no location specified)
Jan 13, 2023
Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)
Recruiting
- Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
- TQB2618 injection azacitidine, AZA decitabine, DAC
-
ChengDu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 16, 2022
Head and Neck Squamous Cell Carcinoma Trial in New Haven (5-Azacitadine)
Completed
- Head and Neck Squamous Cell Carcinoma
-
New Haven, ConnecticutSmilow Cancer Center at Yale New Haven Hospital
Feb 3, 2022
Leukemia, Myeloid Trial in Guanzhou (Decitabine and Ara-C, Ara-C)
Recruiting
- Leukemia, Myeloid
- Decitabine and Ara-C
- Ara-C
-
Guanzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Apr 24, 2020
Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive
Unknown status
- Acute Myeloid Leukemia, in Relapsed or Refractory
- +2 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 8, 2020
Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)
Not yet recruiting
- Acute Kidney Disease
- Azacitidine
- Placebo
-
Taipei City, TaiwanYu Hsiang Chou
May 2, 2022
Premature Birth Trial in Milan (Early Intervention)
Active, not recruiting
- Premature Birth
- Early Intervention
-
Milan, ItalyNICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Feb 2, 2023
T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Oral Azacitidine)
Recruiting
- T-Cell Large Granular Lymphocyte Leukemia
- Oral Azacitidine
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Mercury--Toxicology Trial in Rochester (Tuna fish, prebiotic)
Active, not recruiting
- Mercury--Toxicology
- Tuna fish
- prebiotic
-
Rochester, New YorkUniversity of Rochester Medical Center
Oct 7, 2022
Tinea Versicolor Trial in Abbottabad (Fluconazole, Itraconazole)
Completed
- Tinea Versicolor
-
Abbottābād, Khyber Pakhtunkhwa, PakistanCMH Abbottabad
May 8, 2023
MDS, Chronic Myelomonocytic Leukemia-1, Cytopenia Trial in Denmark, United States (Vitamin C (ascorbic acid), Placebo)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Vitamin C (ascorbic acid)
- Placebo
-
Los Angeles, California
- +4 more
Sep 27, 2021
Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients
Not yet recruiting
- Hiatus Hernia
- Upper Endoscopy
- (no location specified)
Nov 24, 2023
Infant Growth, Childhood Overweight Trial (Betaine supplementation in infant formula, Regular infant formula)
Not yet recruiting
- Infant Growth
- Childhood Overweight
- Betaine supplementation in infant formula
- Regular infant formula
- (no location specified)
Oct 23, 2023
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,
Terminated
- Advanced Solid Tumor
- +3 more
- NTX-301
- +2 more
-
Darlinghurst, New South Wales, Australia
- +1 more
Dec 18, 2022
Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
-
NanJing, ChinaDepartment of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022
Pediatric Surgical Patient Trial in Boston (oral oxycodone)
Recruiting
- Pediatric Surgical Patient
- oral oxycodone
-
Boston, MassachusettsBoston Children Hospital
Jun 6, 2022
Diabetes, Type 2, Cognitive Dysfunction, Epigenetics, Exercise Trial (Aerobic exercise program, Stretching exercise)
Unknown status
- Diabetes Mellitus, Type 2, Cognitive Dysfunction, Epigenetics, Exercise
- Aerobic exercise program
- Stretching exercise
- (no location specified)
Oct 26, 2020
MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +
Recruiting
- Myelodysplastic Syndromes
- +3 more
- Azacitidine
- +2 more
-
Hackensack, New Jersey
- +6 more
Nov 18, 2022
Acute Myeloid Leukemia Trial in Shenyang (rhTPO, Decitabine)
Recruiting
- Acute Myeloid Leukemia
-
Shenyang, Liaoning, ChinaShengJing Hospital of China Medical University
May 16, 2022
Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)
Recruiting
- Malignancy
- Decitabine combined with NK cell infusion
-
Shenzhen, Guangdong, ChinaShenzhen University General hospital
Nov 22, 2021
Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine Combined With Venetoclax and ATRA group
-
Suzhou, Chinathe First Affiliated Hospital of Soochow University
Dec 8, 2022
Acute Myeloid Leukemia Trial in Shenyang (rhTPO)
Recruiting
- Acute Myeloid Leukemia
-
Shenyang, Liaoning, ChinaShengJing Hospital of China Medical University
Feb 17, 2022
AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022
Homocystine; Metabolic Disorder Trial in Islamabad (Homocysteine)
Withdrawn
- Homocystine; Metabolic Disorder
- Homocysteine
-
Islamabad, Capital, PakistanMubin Kiyani
Sep 2, 2021